Glucocorticoids and Antivirals for HBV Reactivation in Cancer Patients
Author Information
Author(s): Marzano Alfredo MD, Marengo Andrea MD, di Fonzo Michela MD, Begini Paola MD, Ferrari Antonella MD, Monarca Bruno MD, delle Fave Gianfranco MD, Marignani Massimo MD
Primary Institution: Università Cattolica del Sacro Cuore
Hypothesis
Can glucocorticoids help manage hepatitis B reactivation in patients with onco-hematological malignancies undergoing chemotherapy?
Conclusion
The study suggests that glucocorticoids may help control immune responses in patients with HBV reactivation, but survival depends on the underlying liver condition.
Supporting Evidence
- One patient improved after treatment with glucocorticoids and antivirals.
- The second patient died due to liver cirrhosis that was undetected before death.
Takeaway
This study looked at two cancer patients who had hepatitis B reactivation after chemotherapy. One patient got better with treatment, but the other sadly passed away due to liver failure.
Methodology
Case reports of two patients with onco-hematological malignancies and HBV reactivation treated with glucocorticoids and antivirals.
Limitations
The study is based on only two case reports, limiting the generalizability of the findings.
Participant Demographics
Both patients were 73 years old and had different types of onco-hematological malignancies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website